Discovery of PMSA Derivative 11 as a Novel Lead Compound for Therapeutic Treatment of Osteoporosis In Vitro and In Vivo-Reference-Cited by-同舟云学术

Discovery of PMSA Derivative 11 as a Novel Lead Compound for Therapeutic Treatment of Osteoporosis In Vitro and In Vivo

Published:2023-05-08 Issue:10 Volume:66 Page:6766-6781
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Zhihao¹,Rajamanickam Karthik Rajan²,Ding Mina¹,Kim Sang Kyoon³^ORCID,Park Sang-wook⁴,Kim Eunae⁵^ORCID,Lee Sunwoo²^ORCID,Lee Tae-Hoon⁴^ORCID

Affiliation:

1. BioMedical Sciences Graduate Program (BMSGP), Chonnam National University, Gwangju 61186, Republic of Korea

2. Department of Chemistry, Chonnam National University, Gwangju 61186, Republic of Korea

3. Preclincial Research Center (PRC), Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu 41061, Republic of Korea

4. Department of Oral Biochemistry, Dental Science Research Institute, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea

5. College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea

Funder

Ministry of Health and Welfare

Ministry of Science and ICT, South Korea

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00114

Reference45 articles.

1. Bone Resorption by Osteoclasts

2. Bisphosphonate-related osteonecrosis of the jaw: an overview

3. Bisphosphonate-associated adverse events

4. Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

5. Bisphosphonate-induced Severe Hypocalcemia - A Case Report -

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss;Bioorganic Chemistry;2024-09

2. Novel Inhibitor of Keap1-Nrf2 Protein–Protein Interaction Attenuates Osteoclastogenesis In Vitro and Prevents OVX-Induced Bone Loss In Vivo;Antioxidants;2024-07-15

3. Discovery of a novel homoisoflavonoid derivative 5g for anti-osteoclastic bone loss via targeting FGFR1;European Journal of Medicinal Chemistry;2024-04

4. Discerning the Impact of Noncovalent Interactions via Simulated Crystal Growth: A Structural Study of Aromatic Esters;Crystal Growth & Design;2024-03-26